Clinical trials: Epithelial-Mesenchymal Transition

Healthy

Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers

• Completed
• Age: 18 to 60 years
• Phase 1
• Results posted

This is a Phase I, open label, randomized, crossover trial to investigate the relative bioavailability of tepotinib in healthy volunteers.

Trial name

NCT03021642

Testing

Tepotinib test (Treatment Period 1), Tepotinib reference (Treatment Period 2), Tepotinib reference (Treatment Period 1)

Where

Germany

Volunteers

24 people, healthy volunteers welcome

Sponsor

Merck KGaA, Darmstadt, Germany